Evidence of the efficacy of Kampo medicine for neurological symptoms
| Project/Area Number |
17K15906
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
General internal medicine(including psychosomatic medicine)
|
|---|
| Research Institution | Tokyo Women's Medical University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2017-04-01 – 2020-03-31
|
| Project Status |
Completed (Fiscal Year 2019)
|
| Budget Amount *help |
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2019: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2018: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2017: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
|
|---|
| Keywords | 漢方 / 頭痛 / めまい / しびれ / 神経内科 / エビデンス / TOMRASS |
|---|
| Outline of Final Research Achievements |
I conducted research to make evidence of Kampo medicine for neurology with original system "TOMRASS" in our clinic. I paid attention to symptoms such as headache, dizziness, and numbness relatively responsive to Kampo medication. For headache, efficacy rate of gosyuyuto, goreisan, and ryokeijutsukanto was 70.0%, 58.8% and 52.9%, respectively. For dizziness, those of ryokeijutsukanto, goreisan and hangebyakujutsutenmato was 48.4%, 63.6% and 54.5%. For numbness, those of hachimijiogan was 38.4%. When I discussed about condition of patients effective to Kampo medication, for instance, ryokeijutsukanto was especially effective to patients with coldness in foot. I revealed new knowledge about Kampo medications.
|
| Academic Significance and Societal Importance of the Research Achievements |
漢方薬の有効例、無効例の判断を各医師の感覚ではなく自覚症状評価システム（TOMEASS）で行ない、有効例、無効例を様々な随伴症状、身体所見などから評価することにより、漢方薬選択における客観的指標を立てることが可能になる。
頭痛、めまい、しびれを有する患者は多く、現代医学での治療効果は限定的であり、QOLは低い。そのような中で、漢方薬をより適切に活用できるようになり、健康レベルが上がることが期待できる。
|
Report
(4 results)
Research Products
(15 results)
